Clinical trial
Clinical Study of TCR-like CAR-T Cell Targeted MSLN in the Treatment of Ovarian Cancer
NCT05963100 is registered in ClinicalTrials.gov with Zhongda Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study of TCR-like CAR-T Cell Targeted MSLN in the Treatment of Ovarian Cancer
- Lead sponsor
- Zhongda Hospital
- Phase
- Phase 1/2
- Overall status
- Active, not recruiting
- Start date
- August 7, 2023
- Completion date
- May 16, 2026
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
safety and efficacy of tcr-like car-t